VANGUARD GROUP INC 13D and 13G filings for GoodRx Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:02 pm Unchanged | 2024-09-30 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 7,912,286 8.020% | 0 (Unchanged) | Filing |
| 2024-11-04 11:58 am Sale | 2024-09-30 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 7,912,286 8.020% | -468,704 (-5.59%) | Filing |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 8,380,990 9.070% | 62,685 (+0.75%) | Filing |
| 2023-03-10 07:59 am Purchase | 2023-02-28 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 8,318,305 10.090% | 489,672 (+6.25%) | Filing |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 7,828,633 9.490% | 1,777,768 (+29.38%) | Filing |
| 2022-02-10 08:16 am Purchase | 2021-12-31 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 6,050,865 7.500% | 2,603,999 (+75.55%) | Filing |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | GoodRx Holdings, Inc. GDRX | VANGUARD GROUP INC | 3,446,866 7.660% | 3,446,866 (New Position) | Filing |